Experimental rotavirus diarrhoea in colostrum-deprived newborn calves: assay of treatment by administration of bacterially produced human interferon (Hu-IFN alpha 2).
Seven colostrum-deprived newborn calves were orally inoculated within 24 hours after birth with bovine rotavirus. Three of them were intramuscularly injected with bacterially produced human interferon (Hu-IFN alpha 2). The four control animals presented a severe diarrhoea for at least 48 hours, while only one of the treated calves suffered from a transient diarrhoea for a few hours. Hu-IFN alpha 2 seems therefore able to control rotavirus diarrhoea in newborn calves, although it did not inhibit virus excretion and seroconversion in the treated animals. Moreover, the administration of endogenous interferon appeared to be well tolerated by newborn calves. The efficacy of human alpha 2 interferon for the treatment of this important virus infection of cattle seems thus well established.
D000821:Animal Feed; D000818:Animals; D002417:Cattle; D002418:Cattle Diseases / Q000628:therapy*; D003126:Colostrum; D003967:Diarrhea / Q000209:etiology / Q000628:therapy / Q000662:veterinary*; D007370:Interferon Type I / Q000627:therapeutic use*; D012400:Rotavirus Infections / Q000628:therapy / Q000662:veterinary*
D007370:Interferon Type I